These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. Borio L; Frank D; Mani V; Chiriboga C; Pollanen M; Ripple M; Ali S; DiAngelo C; Lee J; Arden J; Titus J; Fowler D; O'Toole T; Masur H; Bartlett J; Inglesby T JAMA; 2001 Nov; 286(20):2554-9. PubMed ID: 11722269 [TBL] [Abstract][Full Text] [Related]
9. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925 [TBL] [Abstract][Full Text] [Related]
10. Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Hsu VP; Lukacs SL; Handzel T; Hayslett J; Harper S; Hales T; Semenova VA; Romero-Steiner S; Elie C; Quinn CP; Khabbaz R; Khan AS; Martin G; Eisold J; Schuchat A; Hajjeh RA Emerg Infect Dis; 2002 Oct; 8(10):1039-43. PubMed ID: 12396912 [TBL] [Abstract][Full Text] [Related]
11. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528 [No Abstract] [Full Text] [Related]
12. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Williams JL; Noviello SS; Griffith KS; Wurtzel H; Hamborsky J; Perz JF; Williams IT; Hadler JL; Swerdlow DL; Ridzon R Emerg Infect Dis; 2002 Oct; 8(10):1133-7. PubMed ID: 12396928 [TBL] [Abstract][Full Text] [Related]
13. Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001. Holtz TH; Ackelsberg J; Kool JL; Rosselli R; Marfin A; Matte T; Beatrice ST; Heller MB; Hewett D; Moskin LC; Bunning ML; Layton M Emerg Infect Dis; 2003 Jun; 9(6):689-96. PubMed ID: 12781008 [TBL] [Abstract][Full Text] [Related]
14. Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Dull PM; Wilson KE; Kournikakis B; Whitney EA; Boulet CA; Ho JY; Ogston J; Spence MR; McKenzie MM; Phelan MA; Popovic T; Ashford D Emerg Infect Dis; 2002 Oct; 8(10):1044-7. PubMed ID: 12396913 [TBL] [Abstract][Full Text] [Related]
15. From the Centers for Disease Control and Prevention. Evaluation of Bacillus anthracis contamination inside the Brentwood mail processing and distribution center--District of Columbia, October 2001. JAMA; 2002 Jan 23-30; 287(4):445-6. PubMed ID: 11824387 [No Abstract] [Full Text] [Related]
16. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843 [TBL] [Abstract][Full Text] [Related]
18. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. Mayer TA; Bersoff-Matcha S; Murphy C; Earls J; Harper S; Pauze D; Nguyen M; Rosenthal J; Cerva D; Druckenbrod G; Hanfling D; Fatteh N; Napoli A; Nayyar A; Berman EL JAMA; 2001 Nov; 286(20):2549-53. PubMed ID: 11722268 [TBL] [Abstract][Full Text] [Related]
19. Follow-up of deaths among U.S. Postal Service workers potentially exposed to Bacillus anthracis--District of Columbia, 2001-2002. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(39):937-8. PubMed ID: 14523371 [TBL] [Abstract][Full Text] [Related]
20. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):973-6. PubMed ID: 11724150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]